Infectious Disease Prevention for Health Care Systems

Disturbing Facts:

• Every Year:
  • Approximately 100,000 deaths from U.S. hospital-acquired infections (HAI's) - Forbes.
  • Approximately 2,000,000 total U.S. HAI's - Forbes.
  • Approximately 19,000 deaths from MRSA infections alone - CDC.
  • MRSA is the most common cause of skin infections in emergency rooms - NEJM.
• Causes:
  • Growth and strengthening of antibiotic resistant bacteria - Forbes.
  • Fewer antibiotics developed annually - Forbes.
  • MRSA and others travel airborne via dust particles - U.K. study.
  • MRSA utilizes amoeba for protection, incubation and transportation.
  • Current strategies have poor response rate and poor results.
• Medical Costs:
  • Each HAI directly costs approximately $42,000.
  • Administrative Labor.
  • Capital expenditure for isolation zones.
  • Added legal fees for liability protection.
  • Medicare POA denial propsal.
  • Loss of image and reputation.
  • Mandatory hospital infection rate reporting is imminent.
• Present Methods Are Unsuccessful Due To:
  • Cost in time, labor and equipment.
  • Personnel training and expertise.
  • Patient turnover time crunch.
  • Continuous use in high risk areas.
  • Quality of products...state of the art?

JYMRSA - The "Ideal" Disinfection System:

• Extremely fast acting and KILLS, doesn't simply encapsulate.
• Complete surface/air environments treated.
• Extensive on-going anti-microbial efficacy.
• Non-toxic/benign to the environment - truly "green".
• Non-corrosive to sensitive equipment.
• EPA approved.
• Large spectrum of threats destroyed:
  • Bacterial Organisms
    • MRSA, VISA, VRE, Pseudomonas, Salmonella, E. Coli (ESBL and 0157:H7), Klebsiella, Enterobacter, Proteus
  • Virucidal
    • Influenza A, Influenza B, Norovirus
  • Fungicidal
    • Tests show great efficacy against mycotoxins.
• Highly motivated application personnel.
• Non-disruptive to facility operations schedule.
• COST EFFECTIVE.